4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001614740-26-000003
CHIEF EXECUTIVE OFFICER sold 6,831 shares at $96.19 ($657,088)
- CHIEF EXECUTIVE OFFICER acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Peetz Christopher · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-23 | Exercise or conversion : show line 1 in the form | +12,500 | 176,233 | D | ||
| 2026-01-26 | Sale : show line 2 in the form | −6,831 | $96.19 | $657,088 | 169,402 | D |
| Open-market sales · 6,831 sh · avg $96.19 · $657,088 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-23 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −12,500 | 12,500 | D |
Loading xslF345X05/form4-01272026_040103.xml…